"We will hit that target this year": Manx Care responds to criticism over 2024-25 annual report

CEO discusses missed targets, finances and calls for resignations

The CEO of Manx Care has opened up about the challenges the health body faced over the past financial year following the publication of its latest annual report.

Despite a number of missed targets, Teresa Cope says there were also positive developments over that time and Manx Care is on a surer-footing heading into 2026.

Targets

The reports has highlighted how, between 1 April 2024 and 31 March 2025, the percentage of patients receiving a diagnosis or ruling out of cancer within 28 days of referral fell below the target of 75 percent at 63 percent.

However, thanks to the recruitment of another breast radiologist - who started this month - Ms Cope says that target of 75 percent is going to be achieved. 

Meanwhile, the percentage of patients waiting six weeks or more for a diagnostic test should - as per Manx Care's target - be less than one percent. That figure stood at 58 percent.

And the number of patients waiting for a first consultant outpatient appointment rose to 17,829.

Manx Radio sat down with Manx Care CEO Teresa Cope to find out why some of those key targets have been missed:

The positives

Manx Care also wanted to highlight the positives over this period.

Access to services and patient experience have seen significant enhancements, it says.

It also cites the opening of Summerhill View Care Home, and the Bluebell Suite for families experiencing pregnancy loss, as two examples of how it is responding to the needs of the community.